drugset / Trial / NCT00380328

HKI-272 Ketoconazole Drug Interaction Study

NCT00380328

Phase 1 Completed 24 enrolled Puma Biotechnology, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate a potential pharmacokinetic drug interaction between HKI-272 and ketoconazole when co-administered.

Timeline

Start
2006-10
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Neratinib Small molecule Oral

Indications

No indication recorded.